XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Commitments and Contingencies (Details) - USD ($) |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Sep. 01, 2021 | Jun. 01, 2021 | Jan. 05, 2021 | Jun. 30, 2022 | Jan. 27, 2022 | Apr. 30, 2021 | Mar. 31, 2021 | Jul. 31, 2020 | Apr. 17, 2020 | Sep. 30, 2022 | Sep. 30, 2021 | Jun. 30, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | Nov. 27, 2022 | Feb. 01, 2022
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Employment agreement, description |  |  |  |  |  |  |  |  | The Employment Agreement provided for a base salary of $120,000 and 152,619 of vested shares of the Company’s common stock in April 2020. In addition, Mr. Weisblum shall be eligible to earn a bonus, subject to the sole discretion of the Company’s Board of Directors (“Board”). |  |  |  |  |  |  |  |
Loan payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 42,000 |
Deferred compensation balance |  |  |  |  |  |  |  |  |  |  |  | $ 21,658 |  |  |  |  |
License fee |  |  |  |  |  |  | $ 10,000 | $ 10,000 |  |  |  |  |  |  |  |  |
Research and development expenses |  |  |  |  |  |  |  |  |  | $ 375,795 | $ 70,514 |  | $ 651,750 | $ 217,962 |  |  |
Commercial sale term |  |  |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |
License agreement expire |  |  |  |  |  |  |  |  |  |  |  |  | 15 years |  |  |  |
Sublicense income, description |  |  |  |  |  |  |  |  |  |  |  |  | The Company or Company affiliates shall pay to UMB a percentage of all income received from its sublicensee as follows: (i) 25% of the Company’s sublicense income which is receivable with respect to any sublicense that is executed before the filing of an NDA (or foreign equivalent) for the first licensed product; and (b) 15% of the Company’s sublicense income which is receivable with respect to any sublicense that is executed after the filing of an NDA (or foreign equivalent) for the first licensed product. |  |  |  |
License agreement, description |  |  |  |  |  |  |  |  |  |  |  |  | the Company shall pay UMB; (i) a license fee, (ii) certain event-based milestone payments (see below for payment terms), (iii) royalty payments depending on net revenues (see below for payment terms), and (iv) a tiered percentage of sublicense income. The Company shall pay to UMB a license fee of $75,000, payable as follows: (a) $25,000 shall be due within 30 days following the effective date; and (b) $50,000 on or before the first anniversary of the effective date, which was paid in February 2022. The license fee is non-refundable and is not creditable against any other fee, royalty or payment. The Company shall be responsible for payment of all patent expenses in connection with preparing, filing, prosecution and maintenance of patents or patent applications relating to the patent rights. The Company paid $25,000 license fee on February 17, 2021 and $50,000 in February 2022 which was recorded as prepaid expense and is being amortized over the 15-year term. The Company recognized amortization expense of $4,375 in 2021. During the nine months ended September 30, 2022, the Company recognized amortization expense of $3,750. On December 31, 2021, prepaid expense and other current assets – current amounted $5,000 and prepaid expense – non-current amounts $15,625. On September 30, 2022, prepaid expense and other current assets – current amounted $5,000 and prepaid expense – non-current amounts $61,875 as reflected in the accompanying condensed consolidated balance sheets. |  |  |  |
Royalty payments, description |  |  |  |  |  |  |  |  |  |  |  |  | Royalty Payments Terms: (i)3% on sales of licensed products (as defined in the Master License Agreement) during the applicable calendar year for sales less than $50,000,000; and (ii)5% on sales of licensed products during the applicable calendar year for sales greater than $50,000,000; and |  |  |  |
Prepaid expense and other current assets |  |  |  |  |  |  |  |  |  | 833 |  |  | $ 833 |  | $ 838 |  |
Prepaid expenses non-current |  |  |  |  |  |  |  |  |  | 10,410 |  |  | 10,410 |  | $ 11,034 |  |
Non-refundable cash payment |  |  | $ 500,000 |  |  |  |  |  |  |  |  |  | $ 500,000 |  |  |  |
Net sale percentage |  |  |  |  |  |  |  |  |  |  |  |  | 2.00% |  |  |  |
Licensor share (in Shares) |  |  | 500 |  |  |  |  |  |  |  |  |  | 500 |  |  |  |
Aggregate of converted shares (in Shares) |  |  | 625,000 |  |  |  |  |  |  |  |  |  | 625,000 |  |  |  |
Revenue term |  |  | 15 years |  |  |  |  |  |  |  |  |  | 15 years |  |  |  |
Number of voting shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,000 |  |
Reverse stock split vote, description |  |  |  |  |  |  |  |  |  |  |  |  | In addition, each share of the Series M Convertible Preferred Stock shall be convertible, at any time after the earlier of (i) the date that the Reverse Stock Split Vote is approved by Aikido’s stockholders and (ii) December 31, 2021, at the option of the holder, into such number of shares of Aikido’s common stock determined by dividing the Stated Value by the Conversion Price. “Stated Value” means $1,000. “Conversion Price” means $0.80, subject to adjustment.Prior to the April 12, 2021, issuance of the common stock in lieu of the Series M Convertible Preferred Stock as discussed above, the Company valued the 500 Series M Convertible Preferred stock which was equivalent into Aikido’s 625,000 shares of common stock at a fair value of $0.85 per common share or $531,250 based quoted trading price of Aikido’s common stock on the date of grant. The Company recorded an equity investment of $531,250 (see Note 3) and deferred revenue of $531,250 to be recognized as revenues over the term of the license. |  |  |  |
Deferred revenue |  |  |  |  |  |  |  |  |  | 1,031,250 |  |  | $ 1,031,250 |  |  |  |
Cash received |  |  |  |  |  |  |  |  |  | 500,000 |  |  | 500,000 |  |  |  |
Securities received |  |  |  |  |  |  |  |  |  | 531,250 |  |  | 531,250 |  |  |  |
Recognized revenues |  |  |  |  |  |  |  |  |  |  |  |  | 51,562 |  | $ 68,750 |  |
Deferred revenue current portion |  |  |  |  |  |  |  |  |  |  |  |  | 68,750 |  | 68,750 |  |
Deferred revenue long-term portion |  |  |  |  |  |  |  |  |  |  |  |  | 41,620 |  | 893,750 |  |
Revenue long term portion amounts |  |  |  |  |  |  |  |  |  | 842,187 |  |  | $ 842,187 |  |  |  |
Consideration fee payable percentage |  |  |  |  |  |  |  |  |  |  |  |  | 110.00% |  |  |  |
Upfront license fees |  |  |  |  |  | $ 50,000 |  |  |  |  |  |  | $ 50,000 |  |  |  |
First commercial sale |  |  |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |
Agreement shall expire |  |  |  |  |  |  |  |  |  |  |  |  | 15 years |  |  |  |
Sponsored study agreement, description |  |  | The total cost under the Sponsored Study Agreement shall not exceed $81,474 which is payable in two equal installments of $40,737 upon execution of the Sponsored Study Agreement and $40,737 upon completion of the project with an estimated project timeline of nine months. The Company paid $40,737 on January 13, 2021 which was recorded in prepaid expense to be amortized over the nine-month period. Currently, the project has not been completed due to the delays cause by the Covid-19 pandemic. During the year ended December 31, 2021, the Company fully amortized the prepaid expense of $40,737. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sublicense amount paid |  | $ 342,850 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sponsored research agreement, description |  | The Company paid the first payment of $40,000 pursuant to the payment schedule on the Sponsored Research Agreement on June 15, 2021, the second payment of $40,000 on September 9, 2021 and $20,570 on November 18, 2021, the third payment of $60,570 on March 1, 2022 and a fourth payment of $60,570 in August 2022, which were recorded to prepaid expense and other current assets – current to be amortized over the two-year period. In 2021, the Company amortized $92,855 of the prepaid expense. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Company paid cash | $ 92,095 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Company paid second payment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 92,095
Prepaid expense |  |  |  |  |  |  |  |  |  | 215,412 |  |  | $ 215,412 |  | 359,021 |  |
Prepaid expense related to research |  |  |  |  |  |  |  |  |  |  |  |  | 287,217 |  | $ 71,804 |  |
Payment of university |  |  |  |  |  |  |  |  |  |  |  |  | 5,000 |  |  |  |
Agreement, description |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In 2021, the Company paid $5,000 related to this agreement. During the nine months ended September 30, 2022, the Company paid $15,000 related to this agreement. |  |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salary was increased |  |  |  |  |  |  |  |  |  | 120,000 |  |  | 120,000 |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salary was increased |  |  |  |  |  |  |  |  |  | $ 180,000 |  |  | 180,000 |  |  |  |
Third Amendment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development expenses |  |  |  | $ 2,500 |  |  |  |  |  |  |  |  |  |  |  |  |
Master License Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront license fees |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,900,000 |  |  |  |
JV Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pursuant terms, description |  |  |  |  |  |  |  |  |  |  |  |  | Pursuant to the terms of the JV Agreement, (A) the Company shall contribute (1) $225,000 and (2) its expertise and the expertise of its science advisory board and (B) ZTI shall contribute (1) certain rights to certain of its patented technology as set forth in the JV Agreement, (2) a license to the know-how and trade secrets with respect to its Z-pod™ technology for the loading and release of ketamine, (3) ketamine to be used for clinical purposes, (4) reasonable use of its facilities and permits and (5) its expertise and know-how. Pursuant to the JV Agreement, 51% of the interest in the Joint Venture shall initially be owned by the Company and 49% of the interest in the Joint Venture shall initially be owned by ZTI, subject to adjustment in the event of additional contributions by either party. Notwithstanding the foregoing, in no event shall either party own more than 60% of the interest in the Joint Venture. |  |  |  |
Dr. James Kuo [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Employment agreement, description |  |  |  |  | James Kuo entered into an employment agreement (“Kuo Employment Agreement”) for Dr. Kuo to serve as the Vice President of Research & Development. The Kuo Employment Agreement shall be effective as of the date of the agreement and shall automatically renew for a period of one year at every anniversary of the effective date, with the same terms and conditions, unless either party provides written notice of its intention not to extend the term of the Kuo Employment Agreement at least thirty days prior to the applicable renewal date. Dr. Kuo shall be paid an annual base salary of $30,000. For each twelve-month period of his employment, Dr. Kuo shall be entitled to a bonus whereby amount and terms shall be in the sole and absolute discretion of the Board of Directors (“Board”) and shall be payable at the Company’s sole option in stock or in cash. In addition, an aggregate of 16,000 incentive stock options were granted under the 2020 Plan to Dr. Kou, exercisable at $10.00 per share and expires on January 31, 2032. The stock options vest as follows: (i) 6,000 stock options upon issuance; (ii) 5,000 vests on October 31, 2022 and; (iii) 5,000 vests on October 31, 2023. |  |  |  |  |  |  |  |  |  |  |  |
Stock option (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  | 16,000 |  |  |  |
Fair value of stock option |  |  |  |  |  |  |  |  |  |  |  |  | $ 94,915 |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  | 1.18% |  |  |  |
Expected dividend yield |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |
Expected term |  |  |  |  |  |  |  |  |  |  |  |  | 2 years |  |  |  |
Expected volatility |  |  |  |  |  |  |  |  |  |  |  |  | 117.00% |  |  |  |
Fair value of the unvested stock option |  |  |  |  |  |  |  |  |  |  |  |  | $ 95,915 |  |  |  |
Stock-based Compensation |  |  |  |  |  |  |  |  |  |  |  |  | 73,257 |  |  |  |
Deferred compensation balance |  |  |  |  |  |  |  |  |  |  |  |  | $ 21,658 |  |  |  |
Aikido [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred revenue current portion |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,352 |  |
Deferred revenue long-term portion |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 44,134 |  |
Columbia University [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sponsored research agreement, description |  |  |  |  |  |  |  |  |  |  |  |  | The Company paid the first payment of $430,825 in November 2021 and the second payment of $430,825 in July 2022, which were recorded to prepaid expense and other current assets – current to be amortized over the estimated project timeline of twelve months. On October 13, 2022, the Company entered into an amendment to the Columbia Agreement (the “Columbia Amendment”), pursuant to which the parties agreed to extend the payment schedule, whereby the third payment of $430,825 is due in March 2023 and the remaining payment of $143,607 is due upon completion. |  |  |  |
Sublicense Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and Contingencies (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sublicense income, percentage |  |  |  |  |  | 25.00% |  |  |  |  |  |  |  |  |  |  |
Sublicense agreement amount paid |  |  |  |  |  | $ 12,500 |  |  |  |  |  |  |  |  |  |  |
Recognized amortization expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 628 |  |
Amortization expense |  |  |  |  |  |  |  |  |  |  |  | $ 629 |  |  |  |  |
Deferred revenue current portion |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,352 |  |  |  |
Recognized revenues |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,514 |  | $ 2,514 |  |

X
- Definition This value for aggregate of converted shares. + References No definition available. + Details
Name: | silo_AggregateOfConvertedShares
Namespace Prefix: | silo_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition A contract is a legally binding agreement between two or more parties. + References No definition available. + Details
Name: | silo_AgreementDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Agreement shall expire. + References No definition available. + Details
Name: | silo_AgreementShallExpire
Namespace Prefix: | silo_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition This amount for cash received. + References No definition available. + Details
Name: | silo_CashReceived
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This term used for commercial sale. + References No definition available. + Details
Name: | silo_CommercialSaleTerm
Namespace Prefix: | silo_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | silo_CommitmentsandContingenciesDetailsLineItems
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This amount used for company payments. + References No definition available. + Details
Name: | silo_CompanyPaidCash
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This percentage used for consideration fee payable. + References No definition available. + Details
Name: | silo_ConsiderationFeePayablePercentage
Namespace Prefix: | silo_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition This amount used for deferred revenue long-term portion. + References No definition available. + Details
Name: | silo_DeferredRevenueLongtermPortion
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Deferred revenue long-term portion amounted. + References No definition available. + Details
Name: | silo_DeferredRevenueLongtermPortionAmounted
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Employment agreement, description. + References No definition available. + Details
Name: | silo_EmploymentAgreementDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition First commercial sale. + References No definition available. + Details
Name: | silo_FirstCommercialSale
Namespace Prefix: | silo_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition This description for license agreement. + References No definition available. + Details
Name: | silo_LicenseAgreementDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition License agreement expire. + References No definition available. + Details
Name: | silo_LicenseAgreementExpire
Namespace Prefix: | silo_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fee incurred and are directly related to generating license Expenses. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. + References No definition available. + Details
Name: | silo_LicenseFee
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Licensor share. + References No definition available. + Details
Name: | silo_LicensorShare
Namespace Prefix: | silo_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition This percentage for net sale. + References No definition available. + Details
Name: | silo_NetSalePercentage
Namespace Prefix: | silo_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition This amount used for non-refundable cash payment. + References No definition available. + Details
Name: | silo_NonrefundableCashPayment
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of voting shares. + References No definition available. + Details
Name: | silo_NumberOfVotingShares
Namespace Prefix: | silo_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other. + References No definition available. + Details
Name: | silo_OtherDepreciationsAndAmortization
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This amount used for payment of university. + References No definition available. + Details
Name: | silo_PaymentOfUniversity
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Pursuant Terms. + References No definition available. + Details
Name: | silo_PursuantTerms
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This amount for recognized revenues. + References No definition available. + Details
Name: | silo_RecognizedRevenues
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This term for revenue. + References No definition available. + Details
Name: | silo_RevenueTerm
Namespace Prefix: | silo_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description on reverse stock split vote. + References No definition available. + Details
Name: | silo_ReverseStockSplitVoteDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description on royalty payments. + References No definition available. + Details
Name: | silo_RoyaltyPaymentsDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of securities received. + References No definition available. + Details
Name: | silo_SecuritiesReceived
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Description on sponsored research agreement. + References No definition available. + Details
Name: | silo_SponsoredResearchAgreementDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description on sponsored study agreement. + References No definition available. + Details
Name: | silo_SponsoredStudyAgreementDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of sublicense agreement amount paid. + References No definition available. + Details
Name: | silo_SublicenseAgreementAmountPaid
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sublicense amount paid. + References No definition available. + Details
Name: | silo_SublicenseAmountPaid
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description on sublicense income. + References No definition available. + Details
Name: | silo_SublicenseIncomeDescription
Namespace Prefix: | silo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage sublicense income. + References No definition available. + Details
Name: | silo_SublicenseIncomePercentage
Namespace Prefix: | silo_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront license fees. + References No definition available. + Details
Name: | silo_UpfrontLicenseFees
Namespace Prefix: | silo_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals. Excludes amount related to plans that cover generally all employees (for example, but not limited to, qualified pension plans). + References No definition available. + Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The compensation expense recognized during the period pertaining to the deferred compensation arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 30 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363 + Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(26)(c)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_DeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue recognized that was previously reported as deferred or unearned revenue. + References No definition available. + Details
Name: | us-gaap_DeferredRevenueRevenueRecognized1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase (decrease) in prepaid expenses, and assets classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(16)(a)(2)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_LoansPayable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(7)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherPrepaidExpenseCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(7)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.10) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.10) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_PrepaidExpenseCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_PrepaidExpenseOtherNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_RecognitionOfDeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of recorded unconditional purchase obligation to be paid in remainder of current fiscal year. + References No definition available. + Details
Name: | us-gaap_RecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 912 -SubTopic 730 -Section 25 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares purchased for issuance under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Liability for agreement to continue an employee's salary after termination of employment (but before retirement) including death, disability, or other event. For example, a company may agree to continue a disabled employee's salary for six months. + References No definition available. + Details
Name: | us-gaap_SupplementalUnemploymentBenefitsSalaryContinuation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of operating expense for depreciation and amortization of regulated operation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(b)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_UtilitiesOperatingExpenseDepreciationAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=silo_ThirdAmendmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=silo_MasterLincenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=silo_JVAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=silo_DrJamesKuoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=silo_AikidoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=silo_ColumbiaUniversityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | silo_TypeOfAgreementAxis=silo_SublicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |